Shattuck Labs IncNASDAQ:STTK
- LAST PRICE4.3700
- TODAY'S CHANGE (%)0.2050 (4.9220%)
- Bid / Lots4.3500/ 1
- Ask / Lots6.9700/ 2
- Open / Previous Close4.1800 / 4.1650
- Day Range
- 52 Week Range
- Volume460,485
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STTK |
|---|---|---|
| 09:32 ET | 2558 | 4.24 |
| 09:36 ET | 1050 | 4.2 |
| 09:39 ET | 100 | 4.2 |
| 09:41 ET | 100 | 4.24 |
| 09:45 ET | 400 | 4.2163 |
| 09:48 ET | 1900 | 4.26 |
| 09:50 ET | 1498 | 4.32 |
| 09:52 ET | 8852 | 4.38 |
| 09:54 ET | 5195 | 4.34 |
| 09:56 ET | 1500 | 4.34 |
| 09:57 ET | 3351 | 4.295 |
| 09:59 ET | 200 | 4.32 |
| 10:01 ET | 500 | 4.315 |
| 10:03 ET | 200 | 4.275 |
| 10:08 ET | 2200 | 4.32 |
| 10:12 ET | 400 | 4.33 |
| 10:15 ET | 4729 | 4.28 |
| 10:17 ET | 300 | 4.29 |
| 10:19 ET | 3919 | 4.255 |
| 10:21 ET | 599 | 4.26 |
| 10:24 ET | 1000 | 4.27 |
| 10:26 ET | 2878 | 4.285 |
| 10:28 ET | 51666 | 4.195 |
| 10:30 ET | 3887 | 4.17 |
| 10:32 ET | 200 | 4.17 |
| 10:33 ET | 3227 | 4.21 |
| 10:35 ET | 100 | 4.23 |
| 10:39 ET | 400 | 4.22 |
| 10:42 ET | 822 | 4.225 |
| 10:44 ET | 1200 | 4.21 |
| 10:46 ET | 200 | 4.21 |
| 10:48 ET | 1200 | 4.245 |
| 10:51 ET | 600 | 4.2609 |
| 10:53 ET | 100 | 4.255 |
| 10:55 ET | 100 | 4.255 |
| 10:57 ET | 524 | 4.25 |
| 11:00 ET | 200 | 4.25 |
| 11:02 ET | 1125 | 4.275 |
| 11:04 ET | 620 | 4.27 |
| 11:08 ET | 760 | 4.285 |
| 11:09 ET | 300 | 4.27 |
| 11:11 ET | 700 | 4.27 |
| 11:15 ET | 300 | 4.27 |
| 11:18 ET | 382 | 4.28 |
| 11:24 ET | 200 | 4.28 |
| 11:26 ET | 1163 | 4.3088 |
| 11:27 ET | 219 | 4.31 |
| 11:31 ET | 400 | 4.31 |
| 11:33 ET | 100 | 4.31 |
| 11:36 ET | 3062 | 4.35 |
| 11:38 ET | 773 | 4.35 |
| 11:42 ET | 500 | 4.33 |
| 11:44 ET | 120 | 4.335 |
| 11:45 ET | 1000 | 4.34 |
| 11:47 ET | 1020 | 4.355 |
| 11:49 ET | 100 | 4.35 |
| 11:51 ET | 501 | 4.37 |
| 11:54 ET | 4505 | 4.36 |
| 11:56 ET | 300 | 4.36 |
| 11:58 ET | 200 | 4.37 |
| 12:00 ET | 100 | 4.36 |
| 12:02 ET | 187 | 4.36 |
| 12:03 ET | 1200 | 4.365 |
| 12:05 ET | 300 | 4.365 |
| 12:07 ET | 100 | 4.365 |
| 12:09 ET | 200 | 4.36 |
| 12:12 ET | 400 | 4.35 |
| 12:14 ET | 2102 | 4.345 |
| 12:16 ET | 1492 | 4.36 |
| 12:18 ET | 400 | 4.365 |
| 12:20 ET | 500 | 4.36 |
| 12:21 ET | 239 | 4.36 |
| 12:23 ET | 949 | 4.3501 |
| 12:25 ET | 1354 | 4.36 |
| 12:27 ET | 1286 | 4.375 |
| 12:30 ET | 630 | 4.38 |
| 12:34 ET | 2643 | 4.38 |
| 12:36 ET | 200 | 4.38 |
| 12:38 ET | 300 | 4.38 |
| 12:39 ET | 690 | 4.38 |
| 12:41 ET | 2549 | 4.375 |
| 12:43 ET | 2122 | 4.375 |
| 12:45 ET | 448 | 4.375 |
| 12:48 ET | 100 | 4.375 |
| 12:50 ET | 355 | 4.37 |
| 12:52 ET | 2005 | 4.37 |
| 12:54 ET | 519 | 4.37 |
| 12:56 ET | 1389 | 4.39 |
| 01:01 ET | 800 | 4.4 |
| 01:06 ET | 300 | 4.4 |
| 01:10 ET | 300 | 4.395 |
| 01:12 ET | 1500 | 4.43 |
| 01:15 ET | 301 | 4.42 |
| 01:17 ET | 558 | 4.41 |
| 01:19 ET | 900 | 4.4 |
| 01:21 ET | 200 | 4.39 |
| 01:24 ET | 200 | 4.39 |
| 01:26 ET | 100 | 4.4 |
| 01:28 ET | 246 | 4.39 |
| 01:30 ET | 1970 | 4.4 |
| 01:32 ET | 200 | 4.41 |
| 01:33 ET | 226 | 4.42 |
| 01:35 ET | 691 | 4.41 |
| 01:37 ET | 100 | 4.4 |
| 01:39 ET | 100 | 4.41 |
| 01:42 ET | 200 | 4.41 |
| 01:44 ET | 300 | 4.41 |
| 01:46 ET | 100 | 4.41 |
| 01:48 ET | 627 | 4.39 |
| 01:50 ET | 1045 | 4.4 |
| 01:51 ET | 233 | 4.4 |
| 01:53 ET | 223 | 4.4 |
| 01:55 ET | 700 | 4.42 |
| 01:57 ET | 4309 | 4.41 |
| 02:00 ET | 521 | 4.4 |
| 02:02 ET | 300 | 4.39 |
| 02:04 ET | 798 | 4.4 |
| 02:06 ET | 646 | 4.39 |
| 02:08 ET | 100 | 4.39 |
| 02:11 ET | 210 | 4.38 |
| 02:13 ET | 200 | 4.38 |
| 02:15 ET | 225 | 4.38 |
| 02:18 ET | 236 | 4.38 |
| 02:20 ET | 1000 | 4.39 |
| 02:24 ET | 520 | 4.38 |
| 02:26 ET | 10178 | 4.37 |
| 02:27 ET | 6250 | 4.355 |
| 02:29 ET | 100 | 4.35 |
| 02:33 ET | 237 | 4.35 |
| 02:36 ET | 4260 | 4.37 |
| 02:38 ET | 889 | 4.35 |
| 02:42 ET | 200 | 4.36 |
| 02:44 ET | 1981 | 4.36 |
| 02:45 ET | 1200 | 4.355 |
| 02:47 ET | 2611 | 4.37 |
| 02:49 ET | 400 | 4.36 |
| 02:51 ET | 100 | 4.36 |
| 02:56 ET | 100 | 4.36 |
| 02:58 ET | 500 | 4.36 |
| 03:00 ET | 408 | 4.36 |
| 03:02 ET | 2071 | 4.36 |
| 03:03 ET | 1618 | 4.36 |
| 03:05 ET | 800 | 4.37 |
| 03:07 ET | 1287 | 4.37 |
| 03:09 ET | 638 | 4.37 |
| 03:12 ET | 348 | 4.365 |
| 03:14 ET | 324 | 4.365 |
| 03:16 ET | 819 | 4.37 |
| 03:18 ET | 206 | 4.37 |
| 03:21 ET | 100 | 4.37 |
| 03:23 ET | 1094 | 4.36 |
| 03:25 ET | 542 | 4.35 |
| 03:27 ET | 823 | 4.35 |
| 03:30 ET | 1306 | 4.355 |
| 03:32 ET | 1967 | 4.36 |
| 03:34 ET | 680 | 4.36 |
| 03:36 ET | 648 | 4.36 |
| 03:38 ET | 2283 | 4.35 |
| 03:41 ET | 782 | 4.355 |
| 03:43 ET | 100 | 4.355 |
| 03:45 ET | 8718 | 4.37 |
| 03:48 ET | 200 | 4.36 |
| 03:50 ET | 3400 | 4.36 |
| 03:52 ET | 1529 | 4.365 |
| 03:54 ET | 1975 | 4.37 |
| 03:56 ET | 3094 | 4.36 |
| 03:57 ET | 2354 | 4.36 |
| 03:59 ET | 118477 | 4.37 |
Jun 20, 2024
DJ Shattuck Labs Is Maintained at Buy by HC Wainwright & Co., from 6:32AM ET on Thursday Jun 20, 2024 by Dow Jones
6:32AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 17, 2024
DJ Shattuck Labs Is Maintained at Buy by Citigroup, from 11:04AM ET on Monday Jun 17, 2024 by Dow Jones
11:04AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 14, 2024
DJ Shattuck Labs Is Maintained at Buy by Needham, from 12:01PM ET on Friday Jun 14, 2024 by Dow Jones
12:01PM ET on Friday Jun 14, 2024 by Dow JonesShattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients, from 6:00AM ET on Friday Jun 14, 2024 by Dow Jones
6:00AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 10, 2024
DJ Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment, from 8:04AM ET on Monday Jun 10, 2024 by Dow Jones
8:04AM ET on Monday Jun 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Shattuck Labs Inc | 207.8M | -2.3x | --- |
Inovio Pharmaceuticals Inc | 209.6M | -1.5x | --- |
Aldeyra Therapeutics Inc | 206.8M | -6.9x | --- |
Inhibrx Biosciences Inc | 219.2M | -2.8x | --- |
Rani Therapeutics Holdings Inc | 209.2M | -3.2x | --- |
Greenwich Lifesciences Inc | 209.6M | -22.6x | --- |
Company Information
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Contact Information
- Headquarters
- 500 W. 5Th Street, Suite 100AUSTIN, TX, United States 78701
- Phone
- 512-900-4690
- Fax
- ---
Executives
- Independent Chairman of the Board
- George Golumbeski
- Chief Executive Officer, Co-Founder, Director
- Taylor Schreiber
- Chief Financial Officer
- Andrew Neill
- General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
- Stephen Stout
- Chief Business Officer
- Casi Deyoung
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $207.8M |
|---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | 76.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
